Delivery Order SPE2DB22D3501-SPE2DB25FWC01
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vasopressin 20 Unit/mL vials, with a contract ceiling value of $1,225.55. This delivery order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a firm fixed-price purchase under a competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Vasopressin 20 Unit/ML vials with a ceiling value of $2,124.78. This firm fixed price delivery order, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation and was competitively awarded through open competition. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Vasopressin 40 Unit/100 mL in normal saline solution (100 mL units) with a ceiling value of $3,678.32. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The order...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VASOPRESSIN 20 UNIT/ML VIALML, a medication, with a ceiling value of $3,255.45 and a performance period ending on May 22, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $9,606.34 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565279236 - Vasopressin 1ML 25S, a critical pharmaceutical product, with a performance period through August 23, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for...
- The Defense Logistics Agency awarded a $7,857 delivery order contract to Amerisourcebergen Drug Corporation to supply 4561447436 vasopressin 20 unit/ml vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a firm fixed price agreement by July 11, 2023. The parent company, Amerisourcebergen Corporation, will perform the contract through its corporate office division. No subcontractors or set aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,553.75, is for the delivery of Vasopressin 20 unit/mL vial, a critical medical supply. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,553.80 firm fixed price delivery order is for the supply of Vasopressin 20 unit/ml vial, a critical medication. The award has an ultimate completion date of March 21, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,242.87 firm fixed-price delivery order is for the supply of 20 unit/mL vials of the drug vasopressin, with a completion date of November 16, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $3,706.56 firm fixed price delivery order is for the supply of 20 unit/ml vials of the drug Vasopressin. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWC01Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,696.06 to AmerisourceBergen Drug Corp for Vasopressin 20 Unit/ML Vial on June 18, 2025, with an ultimate completion date of June 20, 2025. This delivery order represents a firm fixed price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA prime contract vehicle enables comprehensive pharmaceutical supply support globally, encompassing specialty medications, brand-name and generic drugs, vaccines, medical devices, and other healthcare commodities across multiple therapeutic domains. This specific delivery order for Vasopressin—a critical medication used in emergency and intensive care settings—exemplifies the company's role in fulfilling specialized medical supply needs for the Defense Health Agency and other federal healthcare systems through the flexible IDC framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 6/18/25 |